Article
Anaheim, CA-The 1997 TNM staging system for renal cell carcinoma is coming under increasing scrutiny from a number of institutions, including UCLA, where researchers have not only called into question the discriminatory power of the system but have gone a step further by proposing an alternative system that they feel offers more accurate prognoses.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.